SPXV:NYE-ProShares S&P 500® ex-Health Care ETF (USD)

ETF | Large Blend |

Last Closing

USD 59.82

Change

-0.12 (-0.21)%

Market Cap

USD 0.02B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Under normal circumstances, the fund will invest at least 80% of its total assets in component securities of the index. The index and fund seek to provide exposure to the companies of the S&P 500® Index (the S&P 500®) with the exception of those companies included in the Health Care Sector.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Large Blend

Symbol Name Price(Change) Market Cap
VTI Vanguard Total Stock Market In..

-0.70 (-0.25%)

USD 429.85B
SPLG SPDR® Portfolio S&P 500 ETF

-0.19 (-0.29%)

USD 45.42B
SCHX Schwab U.S. Large-Cap ETF

-0.20 (-0.30%)

USD 45.04B
GSLC Goldman Sachs ActiveBeta® U.S..

-0.40 (-0.36%)

USD 12.56B
DYNF BlackRock US Equity Factor Rot..

-0.22 (-0.45%)

USD 11.50B
SPTM SPDR® Portfolio S&P 1500 Comp..

-0.18 (-0.26%)

USD 9.00B
SPLV Invesco S&P 500® Low Volatili..

-0.51 (-0.71%)

USD 7.42B
JQUA JPMorgan U.S. Quality Factor E..

-0.27 (-0.48%)

USD 4.91B
SCHK Schwab 1000 ETF

-0.18 (-0.33%)

USD 3.72B
SUSA iShares MSCI USA ESG Select

-0.43 (-0.36%)

USD 3.65B

ETFs Containing SPXV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Large Blend) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.89% 85% B 81% B-
Dividend Return 0.67% 49% F 15% F
Total Return 19.56% 86% B+ 78% C+
Trailing 12 Months  
Capital Gain 29.50% 92% A 82% B
Dividend Return 1.20% 40% F 16% F
Total Return 30.70% 89% A- 80% B-
Trailing 5 Years  
Capital Gain 88.54% 79% B- 84% B
Dividend Return 8.29% 65% D 27% F
Total Return 96.83% 76% C+ 84% B
Average Annual (5 Year Horizon)  
Capital Gain 14.68% 86% B+ 78% C+
Dividend Return 16.04% 86% B+ 77% C+
Total Return 1.36% 67% D+ 31% F
Risk Return Profile  
Volatility (Standard Deviation) 19.78% 36% F 52% F
Risk Adjusted Return 81.12% 69% C- 91% A-
Market Capitalization 0.02B 6% D- 12% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.